What does the evidence say about Broccoli Sprout Skin Health Randomized Trial?

Updated August 2026

Quick Answer

Broccoli Sprout Skin Health Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Almost all of the more than 80 studies addressing SF synergies provide evidence in cell lines or animal models, with many of them utilizing the gold-standard Chou–Talalay method [,] to quantify synergy, rather than merely asserting it without quantitative support.

Key Takeaways

  • 01Almost all of the more than 80 studies addressing SF synergies provide evidence in cell lines or animal models, with many of them utilizing the gold-standard Chou–Talalay method [,] to quantify synergy, rather than merely asserting it without quantitative support. [Fahey Jed W. (2026)]
  • 02As a result, it is difficult to determine which findings are broadly reproducible, which are model-specific, and which combinations have the strongest translational rationale. [Fahey Jed W. (2026)]
  • 03Human evidence also remains limited compared with the large preclinical literature, creating an important gap between mechanistic promise and clinical applicability. [Fahey Jed W. (2026)]
  • 041 2 Supplemental Table S1 3 4 5 6 7 Sulforaphane (SF; 1-isothiocyanato-4-(methylsulfinyl)-butane) is generated when plant myrosinase acts on the glucosinolate glucoraphanin (GR), present at high concentration in broccoli sprouts and other cruciferous vegetables. [Fahey Jed W. (2026)]
The current Migaku evidence database contains 2 reusable source documents for Broccoli Sprout Skin Health Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Almost all of the more than 80 studies addressing SF synergies provide evidence in cell lines or animal models, with many of them utilizing the gold-standard Chou–Talalay method [,] to quantify synergy, rather than merely asserting it without quantitative support. [Fahey Jed W. (2026); evidence level 3] - As a result, it is difficult to determine which findings are broadly reproducible, which are model-specific, and which combinations have the strongest translational rationale. [Fahey Jed W. (2026); evidence level 3] - Human evidence also remains limited compared with the large preclinical literature, creating an important gap between mechanistic promise and clinical applicability. [Fahey Jed W. (2026); evidence level 3] - 1 2 Supplemental Table S1 3 4 5 6 7 Sulforaphane (SF; 1-isothiocyanato-4-(methylsulfinyl)-butane) is generated when plant myrosinase acts on the glucosinolate glucoraphanin (GR), present at high concentration in broccoli sprouts and other cruciferous vegetables. [Fahey Jed W. (2026); evidence level 3] - In this narrative review, we aimed to: (i) synthesize evidence on outdoor and indoor air pollution in asthma and lung function decline; (ii) describe key modulators of pollution-related risk; (iii) evaluate diet and supplementation as effect modifiers; and (iv) outline strategies and recommendations to mitigate pollution-related asthma burden. [Carvalho PA (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Sulforaphane Synergies with Phytochemicals and Pharmaceuticals: Implications for Healthspan †
  2. Air Pollution, Asthma and Diet: From Mechanisms to Prevention Strategies.